How to buy Amarin (AMRN) shares in Australia
Learn how to easily invest in Amarin shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Amarin Corporation plc is a biotechnology business with stocks listed in the US. Amarin shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$4.76 – a decrease of 5.74% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in Amarin
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Amarin. Find the share by name or ticker symbol: AMRN. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Amarin reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$5.65, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Amarin, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Amarin. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Amarin key stats
- Compare share trading platforms
- Is Amarin stock a buy or sell?
- Amarin performance over time
- Can I short Amarin shares?
- Are Amarin shares over-valued?
- Amarin's financials
- How volatile are Amarin shares?
- Does Amarin pay a dividend?
- Have Amarin shares ever split?
- Other common questions
Amarin stock price (NASDAQ:AMRN)Use our graph to track the performance of AMRN stocks over time.
Amarin shares at a glance
|52-week range||US$3.84 - US$9.25|
|50-day moving average||US$5.1446|
|200-day moving average||US$4.905|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$0.01|
Where to buy Amarin stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Amarin stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Considering buying Amarin shares?Before you consider Amarin, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.
Show me how
Amarin price performance over time
|1 week (2021-10-19)||-5.74%|
|1 month (2021-09-24)||-11.85%|
|3 months (2021-07-26)||20.81%|
|6 months (2021-04-26)||-8.11%|
|1 year (2020-10-26)||-2.06%|
|2 years (2019-10-25)||-71.24%|
|3 years (2018-10-26)||-78.32%|
|5 years (2016-10-26)||37.97%|
Is Amarin under- or over-valued?
Valuing Amarin stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amarin's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amarin's P/E ratio
Amarin's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 500x. In other words, Amarin shares trade at around 500x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Amarin's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$10 million (£0.0 million).
The EBITDA is a measure of a Amarin's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$620.4 million|
|Operating margin TTM||1.24%|
|Gross profit TTM||US$482.6 million|
|Return on assets TTM||0.49%|
|Return on equity TTM||0.69%|
|Market capitalisation||US$2 billion|
TTM: trailing 12 months
Shorting Amarin shares
There are currently 17.3 million Amarin shares held short by investors – that's known as Amarin's "short interest". This figure is 1.4% up from 17.0 million last month.
There are a few different ways that this level of interest in shorting Amarin shares can be evaluated.
Amarin's "short interest ratio" (SIR)
Amarin's "short interest ratio" (SIR) is the quantity of Amarin shares currently shorted divided by the average quantity of Amarin shares traded daily (recently around 2.7 million). Amarin's SIR currently stands at 6.42. In other words for every 100,000 Amarin shares traded daily on the market, roughly 6420 shares are currently held short.
However Amarin's short interest can also be evaluated against the total number of Amarin shares, or, against the total number of tradable Amarin shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amarin's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Amarin shares in existence, roughly 40 shares are currently held short) or 0.0476% of the tradable shares (for every 100,000 tradable Amarin shares, roughly 48 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Amarin.
Find out more about how you can short Amarin stock.
Amarin share dividends
We're not expecting Amarin to pay a dividend over the next 12 months.
Have Amarin's shares ever split?
Amarin's shares were split on a 1:10 basis on 17 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin shares which in turn could have impacted Amarin's share price.
Amarin share price volatility
Over the last 12 months, Amarin's shares have ranged in value from as little as US$3.84 up to US$9.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin's is 2.2524. This would suggest that Amarin's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Amarin in the news
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
AMRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Amarin Corporation plc Investors of Class Action and Lead Deadline: December 20, 2021
AMRN ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow Notifies Amarin Corporation plc (NASDAQ: AMRN) Investors of Class Action
Frequently asked questions
More guides on Finder
How to buy BITO ETF units | $40.58
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Why is the AMP share price looking up today?
Shares in the wealth management giant have been largely stable in the last 6 months.
How to invest in the Judo Capital Holdings IPO
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
How to invest in the Alloggio Group IPO
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
How to invest in the Larvotto Resources IPO
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
How to invest in the Vulcan Steel IPO
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
How to invest in the Artrya IPO
Everything we know about the Artrya IPO, plus information on how to buy in.
How to invest in the 8 Au IPO
Everything we know about the 8 Au IPO, plus information on how to buy in.
How to invest in the Radiopharm Theranostics IPO
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
What has prompted the rebound in the Kogan share price?
The online retailer’s shares have lost more than half their value in the last 12 months.
Ask an Expert